news
Genetic catalyst identifies the evolution of antibiotic resistance
Researchers have shown that it is possible to identify genetic catalysts that accelerate the evolution of antibiotic resistance in bacteria...
List view / Grid view
Oxford University
news
Organ-on-chip technology tests for hepatitis B virus
Scientists have become the first in the world to test how pathogens interact with artificial human organs...
news
Inhibiting β-lactamase may reverse antibiotic resistance
By developing a chemical to inhibit β-lactamase enzymes, a significant proportion of antibiotic resistance may successfully be reversed...
news
Genome editing reveals a role for OCT4 in human embryogenesis
Researchers have used genome editing technology to reveal the role of a key gene in human embryos in the first few days of development...
news
New synthetic polio vaccine candidate
A collaborative team of scientists have developed a novel synthetic vaccine with a method grown in plants that uses virus-like particles...
article
Using native mass spectrometry to inform drug discovery
Mass spectrometry (MS) performed under native-like conditions (nMS) is a promising approach for studying protein-drug interactions, and has already informed treatments of some of the most intractable diseases including cancer, diabetes and Alzheimer’s.
news
Queen’s researchers breakthrough discovery in fight against bowel cancer
New research led by Queen’s University Belfast has discovered how a genomic approach to understanding bowel cancer could improve the prognosis and quality of life for patients.
news
Metabolic markers accurately diagnose typhoid fever
Researchers have identified a metabolite 'signature' that can accurately distinguish typhoid from other fever-inducing tropical diseases using patient blood samples.
news
Promising antibiotic programme gets European boost
21 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Researchers at the University of Oxford have been working with two major EU-funded projects to deliver a novel antibiotic programme for clinical development...
news
MAIT cells found to have a role against viruses
23 June 2016 | By Victoria White, Digital Content Producer
Mucosal associated invariant T-cells (MAIT cells) could be twice as important as previously thought, according to Oxford University researchers...
news
JQ1 found to alter how breast cancer cells respond to hypoxia
13 June 2016 | By Victoria White, Digital Content Producer
Results from a study showed that JQ1 slowed tumour growth and limited the number of blood vessels that were produced...
news
Researchers identify new genetic risk factors for endometrial cancer
3 May 2016 | By Victoria White, Digital Content Producer
Researchers also looked at how the identified gene regions might be increasing the risk of cancer, and these findings may lead to new treatments...
news
New biomarkers for TB could lead to improved vaccines
12 April 2016 | By Victoria White, Digital Content Producer
A team of scientists have identified new biomarkers for TB which have shown for the first time why immunity from the widely used BCG vaccine is so variable...
news
Drug discovery crisis linked to bad technology choices
15 February 2016 | By Victoria White
Researchers say drug discovery processes are becoming unsustainably expensive despite huge technological advances because the wrong methods are being used…
news
Researchers uncover the role of PAD4 in cancers
8 February 2016 | By Victoria White
Peptidyl arginine deiminase 4 (PAD4) is a protein that plays a role in the development of inflammatory diseases like arthritis...